Agilon Health (NYSE:AGL) Given New $1.50 Price Target at Benchmark

Key Points

• Agilon Health's price target was cut from $4.00 to $1.50 by Benchmark analysts, while maintaining a "buy" rating on the stock.
• The company reported a $0.25 loss per share for the last quarter, missing expectations and showing a 5.9% year-over-year decline in quarterly revenue.
• Despite recent analyst downgrades, Agilon Health's stock saw a 5.8% increase in trading on Wednesday, with a current market price of $0.93.

Agilon Health (NYSE:AGL - Get Free Report) had its price objective lowered by stock analysts at Benchmark from $4.00 to $1.50 in a research report issued on Wednesday,Benzinga reports. The firm presently has a "buy" rating on the stock. Benchmark's price objective would suggest a potential upside of 72.04% from the company's current price.

Other equities research analysts have also issued research reports about the stock. JMP Securities reaffirmed a "market perform" rating on shares of Agilon Health in a research note on Monday, April 28th. Evercore ISI lowered their price target on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Cowen reissued a "hold" rating on shares of Agilon Health in a research report on Tuesday, April 15th. Barclays lifted their target price on shares of Agilon Health from $2.00 to $3.00 and gave the stock an "underweight" rating in a report on Thursday, May 8th. Finally, Sanford C. Bernstein raised shares of Agilon Health from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and a consensus target price of $4.08.

Agilon Health Trading Down 0.4%

Shares of AGL traded down $0.00 during trading hours on Wednesday, reaching $0.87. 30,405,277 shares of the company traded hands, compared to its average volume of 17,026,470. The company's fifty day moving average price is $2.08 and its two-hundred day moving average price is $3.15. Agilon Health has a 12 month low of $0.71 and a 12 month high of $6.08.

Agilon Health (NYSE:AGL - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The company had revenue of $1.39 billion for the quarter, compared to the consensus estimate of $1.47 billion. Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The company's revenue for the quarter was down 5.9% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.07) EPS. Sell-side analysts anticipate that Agilon Health will post -0.59 EPS for the current year.

Institutional Trading of Agilon Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Intech Investment Management LLC increased its holdings in Agilon Health by 11.5% during the second quarter. Intech Investment Management LLC now owns 132,771 shares of the company's stock valued at $305,000 after buying an additional 13,716 shares during the last quarter. Creative Planning boosted its position in shares of Agilon Health by 17.6% in the second quarter. Creative Planning now owns 170,969 shares of the company's stock worth $393,000 after purchasing an additional 25,548 shares during the period. SG Americas Securities LLC boosted its position in shares of Agilon Health by 60.1% in the second quarter. SG Americas Securities LLC now owns 230,912 shares of the company's stock worth $531,000 after purchasing an additional 86,723 shares during the period. Geode Capital Management LLC boosted its position in shares of Agilon Health by 2.6% in the second quarter. Geode Capital Management LLC now owns 7,156,466 shares of the company's stock worth $16,462,000 after purchasing an additional 178,477 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. boosted its position in shares of Agilon Health by 1,028.9% in the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 789,703 shares of the company's stock worth $1,816,000 after purchasing an additional 719,751 shares during the period.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.